GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PsyBio Therapeutics Corp (TSXV:PSYB.H) » Definitions » FCF Yield %

PsyBio Therapeutics (TSXV:PSYB.H) FCF Yield % : -94.43 (As of Jun. 22, 2024)


View and export this data going back to 2021. Start your Free Trial

What is PsyBio Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, PsyBio Therapeutics's Trailing 12-Month Free Cash Flow is C$-1.20 Mil, and Market Cap is C$1.28 Mil. Therefore, PsyBio Therapeutics's FCF Yield % for today is -94.43%.

The historical rank and industry rank for PsyBio Therapeutics's FCF Yield % or its related term are showing as below:

TSXV:PSYB.H' s FCF Yield % Range Over the Past 10 Years
Min: -188.71   Med: 0   Max: 0
Current: -94.43


TSXV:PSYB.H's FCF Yield % is ranked worse than
99.42% of 1550 companies
in the Biotechnology industry
Industry Median: -14.395 vs TSXV:PSYB.H: -94.43

PsyBio Therapeutics's FCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.


PsyBio Therapeutics FCF Yield % Historical Data

The historical data trend for PsyBio Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PsyBio Therapeutics FCF Yield % Chart

PsyBio Therapeutics Annual Data
Trend Dec21 Dec22
FCF Yield %
-39.38 -119.82

PsyBio Therapeutics Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -54.54 -28.26 -23.20 -25.01 56.70

Competitive Comparison of PsyBio Therapeutics's FCF Yield %

For the Biotechnology subindustry, PsyBio Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PsyBio Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PsyBio Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where PsyBio Therapeutics's FCF Yield % falls into.



PsyBio Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

PsyBio Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-4.669 / 3.89683
=-119.82%

PsyBio Therapeutics's annualized FCF Yield % for the quarter that ended in Jun. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0.452 * 4 / 3.188475
=56.70%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PsyBio Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


PsyBio Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of PsyBio Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


PsyBio Therapeutics (TSXV:PSYB.H) Business Description

Traded in Other Exchanges
Address
4400 Sample Road, Suite 138, Coconut Creek, FL, USA, 33073
PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.

PsyBio Therapeutics (TSXV:PSYB.H) Headlines

No Headlines